Join
Live feed
·
INSIDERFilingvia Quantisnow
Kymera Therapeutics Inc. logo

Chief Medical Officer Gollob Jared exercised 1,473 shares at a strike of $1.66 and sold $186,840 worth of shares (3,114 units at $60.00), decreasing direct ownership by 1% to 118,359 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KYMR (Kymera Therapeutics Inc.) and more on Quantisnow.